Prothena Corp Public (PRTA) Change in Accured Expenses (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Change in Accured Expenses of -$2.2 million for Q1 2026, down 344.18% year-over-year from $910000.0 in Q1 2025, and up 64.44% quarter-over-quarter from -$6.2 million in Q4 2025.
Analysis
Prothena Corp Public (PRTA) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Prothena Corp Public's Change in Accured Expenses history runs 15 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 344.18% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$18.9 million (down 544.66% YoY), while the FY2025 annual figure was -$15.8 million, up 13.78% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$2.2 million, up from -$6.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $8.6 million in Q2 2023, with the low at -$14.5 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is $910000.0 (2025), against an average of -$92705.9.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 11076.92% in 2023, then tumbled 936.52% in 2024.
- Prothena Corp Public's Change in Accured Expenses stood at $39000.0 in 2022, then soared by 11076.92% to $4.4 million in 2023, then tumbled by 54.32% to $2.0 million in 2024, then sank by 413.86% to -$6.2 million in 2025, then jumped by 64.44% to -$2.2 million in 2026.
- Business Quant data shows PRTA's Change in Accured Expenses at -$2.2 million in Q1 2026, -$6.2 million in Q4 2025, and -$1.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Prothena Corp Public | 509.98 Mn | 221.78 Mn | - | -11.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.83 Mn |
| Mar 31, 2026 | -2.22 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -8.81 Mn |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -4.65 Mn |
| Mar 31, 2024 | -14.46 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 8.12 Mn |
| Jun 30, 2023 | 8.65 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 7.72 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 3.71 Mn |
| Sep 30, 2021 | -5.99 Mn |